The best peptides for men are the ones with FDA approval and large trials for a specific diagnosis: semaglutide and tirzepatide for obesity (about 15% to 21% average weight loss), hCG for low testosterone caused by a pituitary problem, and teriparatide or abaloparatide for osteoporosis.[1][2][7][8] The peptides most marketed to men, such as BPC-157, CJC-1295 and MK-677, have no outcome trials showing they make men healthier, stronger or longer-lived.[14][13]
“Best” here means best supported by evidence, not most popular. This guide sorts options by evidence, then walks through what matters in your 30s, 40s and 50s and beyond. For the full topic, see our muscle and metabolism peptides hub.
Evidence-graded table
| Peptide or drug | Evidence level | What was shown | FDA status | Our profile |
|---|---|---|---|---|
| Semaglutide (Wegovy) | FDA-approved for this use | 14.9% weight loss at 68 weeks; 20% fewer major heart events in SELECT[1][3] | Approved: obesity, heart risk | Semaglutide |
| Tirzepatide (Zepbound) | FDA-approved for this use | Up to 20.9% weight loss at 72 weeks[2] | Approved: obesity, sleep apnea | Tirzepatide |
| hCG | FDA-approved for this use | 78% of men with pituitary-type hypogonadism produced sperm on gonadotropins[6] | Approved: hypogonadotropic hypogonadism[7] | hCG |
| Teriparatide (Forteo) | FDA-approved for this use | Spine bone density up 5.9% in men in about 11 months[8] | Approved: osteoporosis in men | Teriparatide |
| Abaloparatide (Tymlos) | FDA-approved for this use | Spine bone density up 8.5% vs 1.2% on placebo in men at 12 months[9] | Approved: osteoporosis in men[10] | Abaloparatide |
| MK-677 (ibutamoren) | Human RCTs (surrogate outcomes) | +1.1 kg lean mass, no strength gain, higher blood sugar[11] | Not approved; FDA safety-risk list[15] | MK-677 |
| CJC-1295 | Small human studies | Raised GH and IGF-1 in healthy adults[12] | Not approved | CJC-1295 |
| Ipamorelin | Small human studies | Raises GH; no body-composition trials in men | Not approved | Ipamorelin |
| BPC-157 | Animal or lab only (plus tiny case series) | Tendon healing in rats; few low-quality human reports[14] | Not approved | BPC-157 |
| TB-500 | Animal or lab only | Wound and tendon repair in animals | Not approved | TB-500 |
Trial results come from different populations and are not head-to-head comparisons.
Start with what works, including non-peptide care
For most men, the biggest gains come from things that are not peptides at all: strength training, enough protein and sleep, blood pressure and cholesterol control, and stopping smoking. Peptide drugs earn a place when there is a diagnosis they treat.
That matters for testosterone. The Endocrine Society says testosterone therapy is for men with consistent symptoms and low levels confirmed on at least two morning blood tests.[4] In the TRAVERSE trial of 5,246 men aged 45 to 80 with low testosterone and heart risk, testosterone gel did not increase major heart events compared with placebo.[5] Our peptides vs TRT comparison covers this choice in detail.
In your 30s: fertility, weight and injuries
Protect fertility first. Testosterone and anabolic steroids switch off the signals that drive sperm production. If you may want children, tell your clinician before starting testosterone. For men whose low testosterone comes from a pituitary or hypothalamic problem, hCG is the approved peptide: in a 2025 meta-analysis of 41 studies and 1,673 men, 78% produced sperm after a median 18 months of gonadotropin treatment.[6][7] See our guide to peptides for male fertility.
Weight. If you have obesity, GLP-1 drugs are the best-studied peptides of any kind. Tirzepatide produced 15.0% to 20.9% average weight loss in SURMOUNT-1, depending on dose.[2]
Injuries. BPC-157 and TB-500 are heavily promoted for tendon and joint injuries. A 2025 systematic review found the human evidence limited to a few small, uncontrolled reports.[14] Physical therapy and orthopedic care remain the standard. Both peptides are prohibited in sport.[16]
In your 40s: metabolism and the hormone question
The 40s are when blood pressure, blood sugar and waistline tend to drift. Semaglutide is the one peptide with outcome data here: in SELECT, men and women with overweight or obesity and heart disease had a 20% lower risk of heart attack, stroke or cardiovascular death on semaglutide than on placebo.[3]
This is also when growth hormone “secretagogues” (drugs that make your pituitary release more GH) get marketed as anti-aging. CJC-1295 raised GH and IGF-1 for days after a single injection in healthy adults, but that study measured hormone levels, not muscle, fat or health outcomes.[12] Raising a hormone level is not the same as improving health. Compare the options in peptides vs SARMs and peptides vs prohormones.
In your 50s and beyond: bone, muscle and heart
Bone. Osteoporosis is underdiagnosed in men. Two peptides are approved for it: teriparatide raised spine bone density by 5.9% at the approved 20 microgram dose,[8] and abaloparatide raised it by 8.5% versus 1.2% on placebo over 12 months in 228 men.[9][10]
Muscle. In the longest trial of MK-677, older adults gained 1.1 kg of lean mass over a year, but strength and function did not improve, fasting blood sugar rose and insulin sensitivity fell.[11] FDA lists MK-677 among compounding substances with significant safety risks.[15] Injected growth hormone itself, given to healthy older people, caused small body-composition changes with frequent side effects such as swelling and joint pain.[13]
Heart. Weight-related heart risk is where semaglutide’s evidence is strongest.[3]
Growth hormone itself. Growth hormone is approved for adults with true growth hormone deficiency, usually from pituitary disease, and the Endocrine Society says that diagnosis requires stimulation testing in most cases, not just a low IGF-1 level.[17] Normal age-related decline is not deficiency. Tesamorelin, an approved GH-releasing hormone analog, has a narrow indication: reducing excess abdominal fat in adults with HIV and lipodystrophy.[18] It is not approved for anti-aging or general fat loss.
Questions to discuss with your clinician
- Do my symptoms and two morning blood tests actually show low testosterone, and what is causing it?
- Do I want to keep my fertility? If so, is hCG a better fit than testosterone?
- Should I have a bone density scan?
- Do I meet the criteria for an approved weight-loss drug?
- If I am considering an unapproved peptide, what are the known risks, and how would we monitor them?
The bottom line
The best peptides for men are approved drugs matched to a diagnosis. For everything else, the honest answer is that we don’t know yet whether they help, and in some cases we know they carry risks.
